INDEGENE
Back to Income Statement
|
INDEGENE Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹2,590 Cr | ₹2,306 Cr | ₹1,665 Cr | ₹966 Cr | ₹643 Cr |
What is the latest Revenue of INDEGENE ?
Year | Revenue |
---|---|
Mar2024 | ₹2,590 Cr |
Mar2023 | ₹2,306 Cr |
Mar2022 | ₹1,665 Cr |
Mar2021 | ₹966 Cr |
Mar2020 | ₹643 Cr |
How is Revenue of INDEGENE Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹2,590 Cr | 12.29 | |
Mar2023 | ₹2,306 Cr | 38.54 | |
Mar2022 | ₹1,665 Cr | 72.27 | |
Mar2021 | ₹966 Cr | 50.30 | |
Mar2020 | ₹643 Cr | - |
Compare Revenue of peers of INDEGENE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDEGENE | ₹13,346.4 Cr | -3.8% | 5.3% | NA | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹410,142.0 Cr | -1.5% | 9.1% | 9.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹145,762.0 Cr | -4.9% | -0.6% | 59.1% | Stock Analytics | |
CIPLA | ₹114,322.0 Cr | -1.8% | 1% | 0.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹111,171.0 Cr | 1.6% | 12.1% | 21.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹92,603.7 Cr | -3% | -0.9% | -7.7% | Stock Analytics |
INDEGENE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDEGENE | -3.8% |
5.3% |
|
SENSEX | -2.9% |
3.1% |
1.8% |
You may also like the below Video Courses